Piper Sandler Maintains Neutral on Steris, Lowers Price Target to $215
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar maintains a Neutral rating on Steris (NYSE:STE) and lowers the price target from $220 to $215.
October 26, 2023 | 4:20 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has maintained a Neutral rating on Steris and lowered the price target from $220 to $215.
The news directly pertains to Steris as Piper Sandler, a reputable financial firm, has maintained a Neutral rating on the company and lowered the price target. This could potentially influence investors' perception of the company and its stock value, but the impact is neutral as the rating remains unchanged.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100